GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All Semaglutide Brands India
Generic SemaglutideType 2 Diabetes
Glenmark Pharmaceuticals logo

GLIPIQGeneric semaglutide for type 2 diabetes in India 2026

by Glenmark Pharmaceuticals · ₹325–440/week · DCGI approved March 2026

Active ingredient
Semaglutide (GLP-1 receptor agonist)
Indication
Type 2 Diabetes
Manufacturer
Glenmark Pharmaceuticals Ltd
DCGI status
Approved March 2026
Price (MRP)
₹325–440/week
Vial-format pricing per weekly dose; pen format priced higher
Format
Vial + Prefilled pen
Prescription
Schedule H — required

How GLIPIQ compares

GLIPIQ is Glenmark's generic semaglutide for type 2 diabetes, available in both multi-dose vial and prefilled pen formats. Glenmark's positioning is value pricing on the vial format — at ₹325–440 per weekly dose, GLIPIQ vials sit in the middle of the Indian generic price band, undercutting branded pen products while staying above Eris/Natco's SUNDAE entry price.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is one of India's top-ten pharma companies with a global respiratory and dermatology franchise. The GLIPIQ launch positions Glenmark in the cardiometabolic space for the first time at scale.

Who is GLIPIQ for?

GLIPIQ is approved in India for type 2 diabetes mellitus in adults. Typically used as add-on therapy when metformin + lifestyle aren't achieving glycaemic targets, or as first-line in T2D patients with established cardiovascular disease, obesity, or chronic kidney disease per RSSDI 2024 guidelines.

Not sure if you qualify? Take the 5-minute Indian-guideline eligibility check →

GLIPIQ for specific conditions

GLIPIQ for type 2 diabetes →GLIPIQ and prediabetes →

GLIPIQ cost in India

MRP for GLIPIQ: ₹325–440/week. Actual pharmacy pricing varies by city, pharmacy, and channel. Online prescription pharmacies typically offer modest discounts off MRP with cold-chain delivery; hospital pharmacy pricing is usually at MRP.

Compare with all India brands: GLP-1 therapy cost in India 2026 →

Compared to other GLP-1 brands in India

GLIPIQ is an Indian generic semaglutide. Same active molecule as Ozempic and Wegovy (Novo Nordisk innovator brands), with clinical efficacy that follows the molecule rather than the brand. Other Indian generics include Sundae, Noveltreat, Obeda, Semaglyn, Sembolic, and Samakind — all at similar price points.

All GLP-1 comparisons →All Indian semaglutide brands →Clinical evidence library →GLP-1 blog (India) →

GLIPIQ — frequently asked questions

Is GLIPIQ available in India? Is it DCGI-approved?+
Yes — GLIPIQ is DCGI-approved and currently available across India. The drug received DCGI approval in March 2026 for type 2 diabetes, manufactured by Glenmark Pharmaceuticals Ltd. It is distributed through licensed retail and online prescription pharmacies and hospital pharmacies across Indian metros and most tier-2 cities. GLIPIQ is a Schedule H drug — a doctor's prescription is required. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
What does GLIPIQ cost in India in 2026?+
GLIPIQ is priced at ₹325–440/week (Vial-format pricing per weekly dose; pen format priced higher). Actual pharmacy pricing may vary by city and channel. For brand-by-brand price comparisons across all India brands, see our cost guide. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Do I need a prescription to buy GLIPIQ?+
Yes — GLIPIQ is a Schedule H drug in India and can only be dispensed against a valid prescription from a registered medical practitioner. Any legitimate online prescription pharmacy will require you to upload your prescription before order fulfillment.
Who is GLIPIQ for?+
GLIPIQ is approved for type 2 diabetes in India. Indian guideline eligibility typically requires BMI ≥27.5 (obesity indication) or HbA1c above target on first-line therapy (T2D indication), often with comorbidities at BMI ≥25. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
How does GLIPIQ compare to Ozempic and Wegovy?+
GLIPIQ contains the same active molecule (semaglutide) as Ozempic and Wegovy. Clinical efficacy is comparable; the difference is brand, manufacturer support, pen design, and price. GLIPIQ (₹325–440/week) is meaningfully cheaper than Ozempic (₹5,660+/month) or Wegovy (up to ₹16,400/month) — useful for cost-sensitive patients on long-term therapy.
Where can I buy GLIPIQ in India?+
GLIPIQ is a Schedule H drug — available through licensed retail and online prescription pharmacies and hospital pharmacies across India with a doctor's prescription. Always buy from a licensed pharmacy to avoid counterfeit products; never use sources that dispense without verifying a prescription. Take the GLP-1 Check 5-minute Indian-guideline assessment to see if you qualify.
Official

Manufacturer announcement

Glenmark Pharmaceuticals — GLIPIQ launch announcement (March 2026)

Additional source

Pearce IP — generic semaglutide India launches

GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.

Are you eligible for GLIPIQ?

Take the free 5-minute triage to check your GLP-1 readiness against Indian clinical guidelines.

Check My Eligibility →

Looking at other brands?

See full price comparison across all 25+ DCGI-approved brands →